1. Home
  2. FNWB vs ASMB Comparison

FNWB vs ASMB Comparison

Compare FNWB & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$9.85

Market Cap

87.9M

Sector

Finance

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$34.19

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWB
ASMB
Founded
1923
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.9M
553.6M
IPO Year
2015
2010

Fundamental Metrics

Financial Performance
Metric
FNWB
ASMB
Price
$9.85
$34.19
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$13.50
$43.40
AVG Volume (30 Days)
33.8K
108.4K
Earning Date
01-28-2026
11-10-2025
Dividend Yield
1.42%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$54,052,000.00
$37,191,000.00
Revenue This Year
$31.86
$42.01
Revenue Next Year
$10.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.47
31.30
52 Week Low
$6.05
$7.75
52 Week High
$12.10
$39.71

Technical Indicators

Market Signals
Indicator
FNWB
ASMB
Relative Strength Index (RSI) 57.79 45.87
Support Level $9.88 $32.25
Resistance Level $10.08 $36.92
Average True Range (ATR) 0.17 1.65
MACD -0.06 -0.57
Stochastic Oscillator 7.32 18.27

Price Performance

Historical Comparison
FNWB
ASMB

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: